National Organ Transplant Act (NOTA)

The National Organ Transplant Act of 1984 (NOTA; Public Law 98-507) is the foundational U.S. federal statute governing organ transplantation.[1] Signed into law on October 19, 1984, it established the national framework for organ procurement and allocation by creating the Organ Procurement and Transplantation Network (OPTN) and the Scientific Registry of Transplant Recipients (SRTR), and it prohibited the transfer of human organs for "valuable consideration", that is, it banned the buying and selling of organs.[1][2] NOTA is the legal basis for the principle that organs are donated, not sold, and for the federally overseen national allocation system.

Background

In the early 1980s, organ transplantation was becoming clinically successful, particularly after the advent of effective immunosuppression, but the United States had no national system to match donated organs to candidates equitably, no uniform oversight, and growing concern about the prospect of a commercial market in human organs.[1][3] Congress responded with NOTA, sponsored in the House as H.R. 4080 (the enacted vehicle), to bring the disparate organizations involved in transplantation under a coordinated national structure and to forestall organ commercialization.[1]

Key provisions

NOTA's principal provisions are:[1][2]

• Creation of the OPTN. NOTA directed the establishment of a national Organ Procurement and Transplantation Network, operated under federal contract by a private, nonprofit entity, to maintain a national list of candidates, operate a computerized organ-matching system, and set allocation policy. See Organ transplantation for the network's role in allocation.
• Creation of the SRTR. It provided for a Scientific Registry of Transplant Recipients to collect and analyze data on transplant outcomes and support evaluation of the system.
• Prohibition on the sale of organs. Codified at 42 U.S.C. §274e, NOTA makes it unlawful "to acquire, receive, or otherwise transfer any human organ for valuable consideration for use in human transplantation," with criminal penalties.[2] The statute expressly excludes from "valuable consideration" the reasonable payments associated with the removal, transportation, processing, preservation, and storage of organs, and the reimbursement of a donor's expenses such as travel and lost wages, preserving the principle of financial neutrality.[2]
• A federal Task Force and grant authority to study transplantation issues and support organ procurement.

Implementation: OPTN, SRTR, and oversight

NOTA placed lead oversight with the Department of Health and Human Services, exercised through the Health Resources and Services Administration (HRSA).[3] The OPTN has historically been operated under contract by the United Network for Organ Sharing (UNOS), which first received the contract in 1986.[3] The detailed rules implementing NOTA, including the OPTN Final Rule at 42 CFR Part 121, which sets the framework for allocation policy and requires that organs be allocated using sound medical judgment and without unjust geographic or other discrimination, give the network its regulatory structure.[4]

Amendments and related legislation

NOTA has been amended several times. Notable measures include:

• The Charlie W. Norwood Living Organ Donation Act of 2007 (Public Law 110-144), which amended NOTA to clarify that kidney paired donation does not constitute a transfer of an organ "for valuable consideration," removing legal uncertainty that had constrained paired-exchange programs.[5] See Living donation.
• The Securing the U.S. Organ Procurement and Transplantation Network Act (Public Law 118-14), enacted September 22, 2023, which amended NOTA to give HHS flexibility to make multiple awards (grants, contracts, or cooperative agreements) for operating the OPTN, removed a statutory funding cap, and separated awards for the network's operation from awards supporting an independent OPTN Board of Directors.[6] This law underpins the ongoing OPTN modernization initiative, under which HRSA established, for the first time, an independent OPTN Board separate from any single contractor and began competitively awarding functions historically performed by UNOS to multiple vendors.[6][7]

Effects and significance

NOTA created the institutional architecture of U.S. transplantation that persists today: a single national waiting list and matching system, a federal data registry, federal oversight, and a firm prohibition on organ sales.[1][3] Its ban on valuable consideration anchors the U.S. (and, more broadly, the international) ethical consensus, reflected in the WHO Guiding Principles and the Declaration of Istanbul, that organ donation must be voluntary and unpaid.[8] The prohibition is also the subject of continuing policy debate, including proposals to expand donor cost-reimbursement and incentives while remaining within the bounds of financial neutrality. The 2023 Securing the U.S. OPTN Act and the modernization that followed represent the most significant structural change to NOTA's framework in nearly four decades.[6][7]

See also

• Organ transplantation · Organ donation
• Living donation
• The donation pathway

References

• National Organ Transplant Act of 1984, Pub. L. 98-507 (Oct. 19, 1984), 98 Stat. 2339. https://www.govinfo.gov/content/pkg/STATUTE-98/pdf/STATUTE-98-Pg2339.pdf ; S.2048, 98th Congress. https://www.congress.gov/bill/98th-congress/senate-bill/2048 ; H.R.4080, 98th Congress. https://www.congress.gov/bill/98th-congress/house-bill/4080
• Prohibition of organ purchases, 42 U.S.C. §274e. https://www.law.cornell.edu/uscode/text/42/274e
• Congressional Research Service. Organ Procurement and Transplantation: Administration, Oversight, and Policy Issues (R48426). https://www.congress.gov/crs-product/R48426 ; HRSA. About the OPTN. https://www.hrsa.gov/optn/about
• OPTN Final Rule, 42 CFR Part 121 (incl. §121.4). https://www.ecfr.gov/current/title-42/chapter-I/subchapter-K/part-121
• Charlie W. Norwood Living Organ Donation Act of 2007, Pub. L. 110-144. https://www.congress.gov/bill/110th-congress/house-bill/710 ; https://www.govinfo.gov/app/details/PLAW-110publ144
• Securing the U.S. Organ Procurement and Transplantation Network Act, Pub. L. 118-14 (Sept. 22, 2023). https://www.congress.gov/bill/118th-congress/house-bill/2544
• HRSA. OPTN Modernization (independent Board; multi-vendor structure). https://www.hrsa.gov/optn-modernization ; A Year in Review (January 2026 update). https://www.hrsa.gov/optn-modernization/updates/january-2026
• World Health Organization. WHO Guiding Principles on Human Cell, Tissue and Organ Transplantation (WHA63.22, 2010). https://www.who.int/publications/i/item/WHO-HTP-EHT-CPR-2010.01